Testing QLM1016 for schizophrenia symptoms
Part of Mental health clinical trials.
This study tests an experimental medication called QLM1016 for people with schizophrenia. It aims to see if the drug helps reduce symptoms like delusions, hallucinations, and disorganized thinking.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 65 years old.
- You have a diagnosis of schizophrenia and currently have moderate or worse symptoms like delusions, hallucinations, disorganized thinking, or unusual thoughts.
- Your overall illness is at least moderately severe.
- You do not have other major mental health conditions like bipolar disorder, schizoaffective disorder, or a severe personality disorder.
- You are not currently in a severe episode that requires a different type of treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication called LB-102 for people with acute (sudden worsening of) schizophrenia. It aims to see if the drug helps reduce symptoms like hallucinations or disorganized thinking.
This trial tests if LY03020 helps people with schizophrenia who are currently having a severe episode. If you have acute symptoms like hallucinations or delusions, this study could be an option.
This trial tests a new medication called VV119 for adults currently experiencing a sudden worsening of schizophrenia symptoms. The goal is to see if it is safe and if it helps reduce symptoms like delusions, disorganized thinking, and hallucinations.
This trial tests a new drug, ML-007C-MA, for adults with schizophrenia who may benefit from ongoing treatment. It aims to see how safe and effective the drug is over a longer period.
This study tests the safety of a new medication called LY03020. It is for healthy volunteers and for people with stable schizophrenia. The study aims to see how well the body handles the drug and what side effects might occur.
This trial tests a new combination pill (xanomeline/trospium) for people who started treatment for schizophrenia in the last 5 years, to see if it helps better than their current medicine. You would stop your current antipsychotic and switch to this study drug under close doctor supervision.
Hear when a new Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.